Identification of CD318 (CDCP1) as novel prognostic marker in AML

Genetic and morphological markers are well-established prognostic factors in acute myeloid leukemia (AML). However, further reliable markers are urgently needed to improve risk stratification in AML. CD318 (CDCP1) is a transmembrane protein which in solid tumors promotes formation of metastasis and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Hematol
Egile Nagusiak: Heitmann, Jonas S., Hagelstein, Ilona, Hinterleitner, Clemens, Roerden, Malte, Jung, Gundram, Salih, Helmut R., Märklin, Melanie, Kauer, Joseph
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Berlin Heidelberg 2020
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7060168/
https://ncbi.nlm.nih.gov/pubmed/31965270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-020-03907-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak